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http:WHAT THIS PAPER ADDS
This is the largest series reporting the mid-term results of fenestrated endovascular aneurysm repair (F-EVAR) to
treat complications after previous standard infrarenal endovascular aortic aneurysm repair (EVAR). This study
shows that F-EVAR is safe and effective in salvaging prior EVAR, and clearly advantageous in terms of periop-
erative mortality and morbidity compared with open conversion. Nevertheless, increased technical difﬁculties
should be expected due to the pre-existing stent graft.Objectives: To review our experience with fenestrated endovascular aneurysm repair (F-EVAR) to treat
complications after previous standard infrarenal endovascular aneurysm repair (EVAR).
Methods: A prospectively maintained database including all consecutive patients with juxtarenal abdominal
aortic aneurysm that were treated with F-EVAR after failed previous EVAR within the period March 2002 to
November 2012 at the University Medical Center of Groningen, Netherlands (up to October 2009), and the
Klinikum Nürnberg Süd, Germany (from November 2009) was analyzed. Evaluated outcomes included initial
technical success, operative mortality and morbidity, and late procedure-related events with regard to survival,
target vessel patency, endoleak, renal function, and reintervention.
Results: A total of 26 patients (24 male, mean age 73.2  6.5 years) were treated. All patients had proximal
anatomies precluding endovascular reintervention with standard techniques. In 23 patients a fenestrated proximal
cuff was used, and in three patients a bifurcated fenestrated stent graft. Technical success was achieved in 24
(92.3%) patients. One patient required on-table open conversion because of impossibility to retrieve the top cap as
a result of twist of the ipsilateral limb. In the second patient the right kidney was lost due to inadvertent stenting in a
smaller branch of the renal artery. Catheterization difﬁculties, all related to the passage through the limbs or struts
of the previous stent graft, were encountered in 11 (42.3%) cases, including ﬁve (19.2%) patients with iliac access
problems and six (23.1%) with challenging renal catheterization. Operative target vessel perfusion success rate was
94.6% (70/74). Operative mortality was 0%. Mean follow-up was 26.8 28.5 months. No proximal type I endoleak
was present on ﬁrst postoperative CTA. The mean aneurysm maximal diameter decreased from 73  20 mm to
66.7 21mm (p< .05).There were six late deaths, one of them aneurysm related. Estimated survival rates at 1 and
2 years were 94.1  5.7% and 87.4  8.4%, respectively. Patency during follow-up for the target vessels treated
successfully with a fenestrated stent graft was 100% (70/70). Reintervention was required in four cases, including
one acute conversion due to rupture, one for iliac limb occlusion and two for type Ib and II endoleak. Renal function
deterioration was observed solely in the two cases of primary technical failure.
Conclusions: F-EVAR represents a feasible option for the repair of juxtarenal abdominal aortic aneurysm after prior
EVAR failure. It is advantageous in terms of mortality and less morbid than open surgery, but is associated with
increased technical challenges because of the previously placed stent graft. Outcome seems related to initial technical
success.
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Proximal type I endoleak is the most feared complication
after standard endovascular aneurysm repair (EVAR) during
follow-up. Inadequate proximal sealing may result from
poor indication or planning (too short neck, undersized
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stent graft migration, and extension of aneurysmal degen-
eration during follow-up. Proximal type I endoleak is asso-
ciated with an increased risk for aneurysm rupture, thus
treatment is strongly advocated.1,2 In the presence of a
suitable infrarenal neck an additional proximal endovascular
stent-graft (i.e., cuff) can be used. In unfavorable anatomy,
other options such as extensive coiling or conversion to
open repair have been used.3 Reports of coiling for proximal
type I endoleak are scarce and indicate suboptimal efﬁcacy.4
Conversion to open surgery is invasive and often technically
challenging, resulting in higher mortality and morbidity.5
Fenestrated endovascular aneurysm repair (F-EVAR) is
now an established technique for treatment of short-necked
and pararenal aneurysms, with excellent early and mid-term
outcomes.6e8 F-EVAR has also been used to repair type I
endoleak after previous EVAR, with initial experience pub-
lished.9 However, no larger series or follow-up reports have
been published. In the present paper, we report the mid-
term outcomes of F-EVAR after failed standard EVAR in 26
consecutive patients.PATIENTS AND METHODS
All consecutive patients with juxtarenal abdominal aortic
aneurysm (AAA) treated with F-EVAR after failed previous
EVAR within the period March 2002 to November 2012
under the supervision of the senior author were included in
this study. Data were prospectively collected. The study was
approved by our institution’s ethical committee and all
patients provided their informed consent.
Aneurysm morphology was assessed by thin cut
(1.5 mm) spiral computerized tomography angiography
(CTA) with axial and coronal reconstructions. Digital sub-
traction angiography (DSA) was also performed preopera-
tively when deemed necessary. Infrarenal neck length (H1)
was deﬁned as the distance between the lowest renal artery
(regardless of supra- or infrarenal ﬁxation), to the beginning
of diseased, dilated aorta. The physical status of all patients
was assessed preoperatively with the American Society of
Anesthesiologists (ASA) score.
Fenestrated stent grafts were customized based on the
Cook Zenith system (William A. Cook Australia, Ltd., Bris-
bane, Australia) according to preoperative measurements to
ﬁt fenestrations and/or scallops for the visceral vessels.
Stent grafts were oversized by 10e15%. Three types of
fenestrated stent grafts were used depending on the aortic
anatomy. A fenestrated cuff was utilized if distal sealing
could be achieved within the body of the pre-existing stent-
graft. In cases where distal landing in the iliac arteries was
deemed necessary, a bifurcated fenestrated graft (with a
contralateral iliac limb) was initially used, and thereafter a
composite stent graft (fenestrated tube þ bifurcated graft
with contralateral limb) that became later available.
The procedures were performed either in the operating
theatre using a mobile C-arm (OEM 9800, General Electric
Medical Systems, Salt Lake City, UT, USA, and Arcadis
Avantic, Siemens AG, Forchheim, Germany) or (later) in ahybrid operating room (OR) with a ﬁxed C-arm system (Artis
Zeego, Siemens AG, Forchheim, Germany). The operation
was carried out under general, epidural, or local anesthesia
according to surgeon, anesthesiologist, and patient prefer-
ences. The stent graft deployment technique has been
previously described in detail.7,8 Technical success was
deﬁned as an endovascularly completed procedure with
absence of type I or III endoleak and patent target vessels.8
Postoperatively, patients were evaluated with clinical and
laboratory examination prior to discharge along with CTA at
1 month, 1 year, and annually thereafter. Upon suspicion of
endoleak or branch vessel malperfusion, additional DSA for
further evaluation and possible reintervention was carried
out. Pre- and postoperative renal function was monitored
by serum creatinine and estimated glomerular ﬁltration rate
(eGFR) measurement.Data analysis
SPSS for Windows (version 17.0; SPSS Inc, Chicago, IL, USA)
was used for statistical analysis. Variables are presented as
mean  standard deviation (SD) in case of normal distri-
bution, and median plus range if data had a skewed dis-
tribution. Statistical signiﬁcance was taken at p < .05.
Analyzed outcomes included technical success, operative
mortality and morbidity, and late-procedure-related events
with regard to target vessel patency, endoleak, renal func-
tion, and reintervention. Survival and reinterventions during
follow-up were subjected to KaplaneMeier analysis.
RESULTS
Patients
A total of 26 patients (24 male, two female; mean age mean
age 73.2  6.5 years) were treated with F-EVAR after pre-
vious failed EVAR. Eighteen (69.2%) patients were classiﬁed
as ASA III and eight (30.8%) patients as ASA II. Mean pre-
operative eGFR was 60.3  17.9 mL/min/1.73 m2, with nine
(34.6%) patients having an eGFR<60 mL/min/1.73 m2.
Mean preoperative serum creatinine was 112.3  36 mmol/
L. Patient comorbidities and risk factors are listed in Table 1.Previous stent-grafts and current aneurysm characteristics
Median time interval from previous EVAR to F-EVAR was 41
months (range, 3e152 months). Ten (38.5%) patients had
their previous EVAR in the centers of this study and 16
(61.5%) patients were referred from elsewhere. All initially
implanted stent grafts were bifurcated. Nine (34.6%) pa-
tients were previously treated with a Zenith stent graft
(Cook Inc, Bloomington, IN, USA), seven (26.9%) with a
Powerlink stent graft (Endologix, Irvine, CA, USA), ﬁve
(19.2%) with a Talent (Medtronic World Medical, Sunrise,
FL, USA), two (7.7%) with an Anaconda (Vascutek,
Inchinnan, UK), two (7.7%) with an Excluder (W.L. Gore &
Associates, Flagstaff, AZ, USA), and one (3.8%) with a
Vanguard stent graft (Boston Scientiﬁc, St Quentin-en-
Yvelines Cedex, France). Mean maximal AAA diameter was
73  20 mm. Mean infrarenal aortic neck length (H1) before
Table 1. Preoperative patient characteristics.
Comorbidity risk factor Patients, n (%)
CAD 19 (73)
Hypertension 19 (73)
COPD 7 (27)
Smoking (current or past) 15 (58)
Diabetes mellitus 5 (19)
Hypercholesterolemia 18 (69)
Serum creatinine > 100 mmol/L 12 (46)
Previous stroke/TIA 3 (11.5)
Hostile abdomen 6 (23)
ASA III 18 (69)
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive
pulmonary disease; TIA ¼ transient ischemic attack;
ASA ¼ American Society of Anesthesiologists.
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0 mm to 10 mm. Mean proximal neck diameter was
increased from 24.3  3.2 mm before the initial EVAR to
26.2  3.7 mm before the current F-EVAR procedure
(p < .05). Twenty-ﬁve patients had a proximal type I
endoleak and/or migration. One patient had aneurysm
growth without manifest endoleak (endotension) but only a
minimal sealing zone length. Table 2 shows the postulated
causes for initial EVAR failure.Figure 1. Bifurcated fenestrated stent-graft featuring an internal
limb in order to be accommodated in the limited working length
within the pre-existing stent-graft.Devices
In 23 (88.5%) patients a fenestrated proximal cuff was used,
in two (7.7%) patients a bifurcated fenestrated stent graft
and in one (3.8%) patient a composite bifurcated conﬁgu-
ration. The two bifurcated stent grafts featured a bifurcation
with an internal limb (i.e., limb inside the tube, Fig. 1) to
accommodate the shorter “working” length inside the main
body of the pre-existing stent graft.9 The total number of
fenestrations/scallops was 74, including 49 renal artery, 21
superior mesenteric artery (SMA), and four celiac artery
(CA) fenestrations (Table 3). In 18 (69.2%) patients a stent
graft targeting renal arteries and the SMA was used, with
the most common combination (16 patients) being two
small fenestrations for the renal arteries and a scallop for
the SMA. A four-fenestration device with three small fen-
estrations for the renal arteries and the SMA, and a scallop
for the CA was implanted in three (11.5%) patients. A two-
fenestration stent graft was used in three (11.5%) patients
and a stent-graft with one fenestration in two (7.7%) pa-
tients. Target vessels were secured with balloon expandableTable 2. Possible causes for endovascular aortic aneurysm repair
(EVAR) failure in the 26 patients.
Reason for EVAR failure n %
Low initial stent-graft placement 7 27
Stent-graft migration 6 23
Extension of disease 6 23
Short initial necka 5 19
Undersized initial stent-graft 2 8
a Refers to the neck length before the ﬁrst EVAR procedure and
was deﬁned as length <10 mm.Advanta V12 covered stents (Atrium Europe, Manchester,
UK) in 24 patients, Genesis balloon expandable stents
(Cordis Corporation, Miami Lakes, FL, USA), and Bridge renal
bare stents (Medtronic AVE Inc., Santa Rosa, CA, USA) in
one patient each.Operative details
All procedures were performed through bilateral femoral
access. Target vessels were catheterized from below with
the standard technique, through separate 5F sheaths
inserted in the valve leafs of a large 20F sheath via
contralateral femoral access. In 23 patients (88.5%) theTable 3. Fenestration type and target vessel distribution
incorporated in the fenestrated stent-graft.
Target vessel Fenestration type Total
Small fenestration Scallop
Right renal artery 20 4 24
Left renal artery 23 2 25
SMA 4 17 21
CA 0 4 4
Total 47 27 74
SMA ¼ superior mesenteric artery; CA ¼ celiac artery.
Figure 2. Computed tomography angiography demonstrating type
Ib endoleak due to inadequate iliac graft limb wall apposition. This
patient suffered a contained rupture and underwent acute
conversion.
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(7.7%) patients under epidural anesthesia, and in one
(3.8%) patient under local anesthesia. Median operative
time was 150 min (range, 85e540 min) and median esti-
mated blood loss (EBL) was 200 mL (range, 90e3000 mL).
Median ﬂuoroscopy time was 30 min (range, 5e85 min) and
mean iodinated contrast volume used 149.4  33 mL.
Thirteen (50%) procedures were performed with a mobile
C-arm and 13 (50%) in a hybrid OR with a ﬁxed C-arm
system.
Technical success and intraoperative technical issues
Technical success was achieved in 24 (92.3%) patients. In
two patients the procedure was not successful. One patient
underwent intraoperative open conversion. Repositioning
maneuvers to reorient the bifurcated fenestrated stent-
graft caused twisting of the ipsilateral limb, which made it
impossible to retrieve the top cap. Additional manipulations
to retrieve the top cap resulted in crushing of both renal
stents, which prompted acute conversion. In the second
patient, the right renal artery was not correctly cathe-
terized, resulting in deployment of the covered stent in a
branch of the main renal artery with kidney loss. Operative
target vessel perfusion success rate was 94.6% (70/74).
In 11 (42.3%) patients, iliac and renal artery access
proved difﬁcult. In ﬁve (19.2%) patients iliac access through
the previous stent-graft was tedious and caused some
dislodgment of the pre-existing stent-graft and alterations
in the available working length. In one of these patients the
iliac limb of the previous stent-graft (Vanguard) was dis-
located during the insertion of the contralateral limb of the
bifurcated fenestrated stent-graft and was repaired with a
bridging stent-graft. In a second patient previous stent-graft
dislodgment resulted in inadequate overlap between the
body of the pre-existing stent-graft and the fenestrated cuff,
which led to the use of an extra aortic cuff (Zenith TX2 TAA,
ESBE-30-80-T endovascular graft distal extension [William A.
Cook Europe, Bjaeverskov, Denmark]). In six (23.1%) pa-
tients renal artery access was tedious. In ﬁve (19.2%) pa-
tients renal artery wire catheterization was initially feasible,
but subsequently the catheter and/or the guiding sheath
could not be advanced over the wire because of interfer-
ence with a suprarenal stent-strut of the previous stent-
graft. Therefore the wire was retrieved and a new cathe-
terization attempted aiming to ﬁnd another entry hole,
which ﬁnally allowed the catheter and guiding sheath to
follow the wire. In the sixth patient with a Powerlink stent-
graft and two additional suprarenal proximal cuffs and two
Palmaz stents (Cordis Corporation, Bridgewater, NJ, USA),
both renal arteries were catheterized and the Palmaz stent
struts dilated in a separate procedure in order to ensure
subsequent catheterization of the renal arteries, as re-
ported earlier.10
Postoperative mortality and morbidity
There was no surgical mortality. Major complications
occurred in two (7.7%) patients. The patient that hadundergone open conversion developed respiratory insufﬁ-
ciency and renal function deterioration requiring an inten-
sive care unit stay for 8 days and prolonged hospital stay. He
was ﬁnally discharged in good condition but with impaired
renal function (20% eGFR decrease), which returned to
preoperative levels 6 months later. The patient in whom we
lost the right kidney due to a technical error required per-
manent dialysis 1 month after the procedure as the left
kidney preoperatively had a diminished function. Four
(15.4%) patients suffered minor complications, including
one retroperitoneal hematoma (conservative treatment),
one bilateral renal hematoma, and two cases of urinary
retention. Median hospital stay was 6 days (range, 3e22
days).
Follow-up
Mean follow-up was 26.8  28.5 months. One patient was
lost to follow-up after 18 months due to old age and poor
general condition. All-cause late mortality was six patients,
ﬁve of them aneurysm unrelated. One patient died after
open conversion for contained aneurysm rupture 9 months
after the F-EVAR procedure. This 86-year-old patient had an
unremarkable imaging follow-up, up to 7 months after the
procedure, but was admitted to another hospital with a
symptomatic aneurysm and a large type Ib endoleak
(Fig. 2). The patient collapsed 3 hours after admission and
was treated urgently with open conversion, but died from
complications 3 days after the procedure. Fig. 3 demon-
strates the cumulative survival curve as estimated with
KaplaneMeier analysis. Estimated survival rates were
94.1  5.7 and 87.4  8.4% at 1 and 2 years, respectively.
Target vessel patency for the branches treated successfully
with a fenestrated stent-graft was 100% (70/70). Mean
Figure 3. KaplaneMeier estimate of the cumulative overall patient
survival for all-cause mortality during follow-up.
Figure 4. KaplaneMeier estimate of freedom from reinterventions
during follow-up.
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66.7  21 mm (p < .05). Renal function during follow-up
remained unchanged in 24 patients (92.3%). The two pa-
tients with renal function problems have been described
above.
During follow-up, major complications occurred in ﬁve
(19.2%) patients and reintervention was required in four
(15.4%) cases. The case of rupture requiring acute conver-
sion has been described above. Two patients had an iliac
limb occlusion. One iliac limb occlusion was diagnosed 3
years postoperatively in the patient with the intra-
operatively dislocated Vanguard limb and was left un-
treated since it was asymptomatic. The second iliac limb
occlusion was diagnosed in conjunction with a disconnected
left iliac limb 6 years after the F-EVAR procedure and was
treated with an aorto-uni-iliac stent-graft and a femoro-
femoral bypass graft. A fourth patient developed a type Ib
endoleak, which was treated with internal iliac artery
embolization and limb graft extension to the external iliac
artery. Finally, one more patient required reintervention
due to persistent type II endoleak. Fig. 4 demonstrates the
estimated cumulative freedom from reinterventions during
follow-up.
DISCUSSION
Open surgical repair of short necked and pararenal AAA is
challenging and often requires suprarenal clamping and
renal artery revascularization, which can increase mortality
and morbidity rates.11,12 The presence of a stent-graft,especially if with suprarenal ﬁxation, poses additional sur-
gical difﬁculties and leads to signiﬁcant increase in periop-
erative mortality and morbidity because of the risk of
visceral aortic segment damage during stent-graft explan-
tation.5,13e15 In a recent series, operative mortality and
morbidity of elective open conversion after EVAR reached
8.8% and 65%, respectively.13 Whereas distal complications
after previous EVAR can easily be treated with endovascular
techniques, a complication at the proximal sealing site is
more tedious to repair, especially if a proximal neck is
missing. In such cases F-EVAR could be the best option. The
present series suggests that F-EVAR can indeed offer a safe
and effective alternative treatment to open conversion after
failed EVAR. Despite the high-risk proﬁle of our patient
cohort, operative mortality was zero. Perioperative
morbidity in the patients treated successfully was low,
allowing for short hospital stay and prompt return to
normal activity. Target vessel patency remained high during
follow-up and so was the freedom from reintervention. This
is the largest study in the literature reporting F-EVAR for
prior EVAR salvage in patients with juxtarenal AAA. Apart
from our earlier report,9 there is one additional paper,
describing successful F-EVAR following EVAR in three
patients.16
As shown in Table 2, the reasons for failure of the initial
EVAR procedure were related to poor indication, or too low
positioning of the stent-graft to start with, or due to
migration or extension of disease at a later stage. Short
proximal neck (<10 mm) in particular and extension of
disease in relatively short necks (10e15 mm) was the main
Figure 5. Computed tomography angiography with three-
dimensional volume rendering technique demonstrating a fenes-
trated cuff with two small fenestrations (renal arteries) and a
scallop (superior mesenteric artery) deployed within the pre-
existing Powerlink stent-graft (Endologix, Irvine, CA, USA).
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AAA with standard EVAR will achieve initial sealing in most
cases, as reported in the literature. However, longer term
data are often poor and underreported. In addition, most
articles that report good results of EVAR in short necks do
include limited patient cohorts with mixed adverse neck
characteristics. Moreover, there are multiple reports that
underline the higher perioperative mortality and morbidity
and increased proximal endoleak rates of standard EVAR in
short-neck AAA.17 Theoretically, many of our patients would
have been better treated initially with F-EVAR; however, this
was commonly unavailable at the time (late 1990s) at the
center of initial EVAR operation.
Migration accounted for 23% of prior EVAR failures.
Interestingly, 62% of the pre-existing stent-grafts in our
patients had a design that is expected to diminish the risk of
migration, either by suprarenal ﬁxation (e.g., Zenith), or by
enabling device accommodation on the aortic bifurcation
(e.g., Powerlink). These data, however, more likely represent
a selection bias and do not necessarily reﬂect the perfor-
mance of the different stent-graft types with regard to
migration resistance. Migration resistance has been previ-
ously studied and is beyond the scope of the present
paper.18
Despite the high technical success and target vessel
preservation rates observed in this series, a number of
technical difﬁculties should be reported and taken into
account before attempting this technique. One case
required acute conversion, since we were unable to
retrieve the top cap due to twisting of the iliac limb. This
occurred in a bifurcated fenestrated stent-graft after
extensive reorientation. By paying more attention to the
deployment of the limb we could have untwisted the limb
and probably avoided the conversion. The potential prob-
lem of a twisted limb was quickly addressed by the com-
pany in changing towards a composite system consisting of
a fenestrated tube, followed by a bifurcated graft and a
contralateral limb. In case of F-EVAR after EVAR, however, a
composite system is usually not applicable because of
shorter “working” length within the body of the previous
stent-graft. This often prompted us to use a fenestrated
tube (i.e., cuff) only (Fig. 5). A fenestrated cuff only seems
to be a reasonable option in these cases although one
could argue that more stability would be achieved with a
complete relining (cuff þ bifurcated þ contralateral limb).
In the current series, fenestrated cuffs only were used in
88.5% of the cases. No migration or disconnection was
noticed during follow-up. Additional surveillance is needed
in order to prove long-term durability of such a
conﬁguration.
Access difﬁculties have also to be expected due to the
presence of an earlier stent-graft. Although technical tricks
including buddy wires, manual compression or stabilization
of the stent-graft with a balloon can be helpful, and all were
used when needed, the risk of dislodging a stent-graft
component is inherent. Changing the position of the pre-
vious stent-graft can result either in inadequate overlap
between the pre-existing and the current fenestrated stent-graft, or in a shorter than estimated working length. In the
latter case one can attempt to pull the previous stent-graft
down again using a compliant balloon through the contra-
lateral limb. A particular problem occurs in patients previ-
ously treated with a Powerlink stent-graft. This graft
features the stent on the inside of the graft, without com-
plete attachment. This allows enough room for a guidewire
to be trapped between the graft and the struts, which can
cause serious problems with wire access, especially in
angulated anatomy. To make sure that the wire is not
trapped behind a strut we routinely pass an inﬂated an-
gioplasty balloon over the guide wire before inserting and
deploying the device.
Renal artery catheterization can similarly be more
demanding when performed within already implanted
stent-grafts. Poorer image quality and visualization of the
fenestrations due to overlapping stent-grafts, and re-
strictions during catheter and guiding sheaths movements
have to be expected due to interference with the already
placed stent-grafts. The struts of the suprarenal uncovered
part of the initial stent-graft that crosses the renal arteries
can also cause problems. In ﬁve (19%) cases we had to
recatheterize the artery until we found the best entry (i.e.,
the biggest gap between wall and a crossing strut). In one
patient initially treated with a Powerlink stent-graft, with
two proximal cuffs with suprarenal ﬁxation and two Palmaz
stents placed over the renal arteries, we decided to ﬁrst
catheterize and dilate the Palmaz stent struts across the
renal oriﬁces in order to ensure renal catheterization during
the F-EVAR procedure.10 All these additional technical
challenges make the procedure more difﬁcult than standard
F-EVAR in a native aorta.
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such cases, to enable visualization of the radiopaque
markers inside the previous stent-graft and allow for cath-
eterization of the fenestrations and target vessels. Exact
positioning of the bridging stent-grafts with correct pro-
trusion into the main stent-graft also requires the highest
quality of ﬂuoroscopy. In our experience a hybrid suite with
a ﬁxed C-arm system is indispensable to address such
complex cases. Not only the better image quality, but also
the ease of use in terms of ergonomics and three-
dimensional fusion options helps achieve success in these
cases.
During follow-up, one aneurysm-related death occurred.
This 86-year-old patient was treated with a fenestrated cuff
12 years after the initial EVAR because of proximal exten-
sion of disease. Seven months after the procedure the pa-
tient was admitted with a symptomatic aneurysm due to a
large distal type Ib endoleak (Fig. 2). Unfortunately, rupture
occurred within 3 hours, resulting in an acute open con-
version. In retrospect, it would have been better to extend
the iliac graft limb to seal the massive endoleak. Overall,
late complications during follow-up occurred in 19.2%,
delineating the need for close long-term surveillance of
these patients.
An alternative endovascular treatment for selected pa-
tients with proximal type I endoleak could potentially be
the stabilization of the previous stent-graft with endoan-
chors (HeliFX, Aptus Endosystems Inc., Sunnyvale, CA, USA).
The latter have already been used successfully, most
commonly combined with implantation of a proximal cuff in
patients with adequate infrarenal neck length.19 Our patient
cohort, however, was not appropriate for such a combined
procedure (proximal cuff þ endostapling) because of very
short or no proximal neck.
This study has some limitations and its outcomes
should be carefully interpreted. The presented results
originate from selected patients and do not represent
outcomes on consecutive patients with failed EVAR.
During the study period, we also treated a number of
patients with open conversion and standard cuffs when a
sufﬁcient neck was still present. The referral bias should
be also noted, as we do get the patients referred from
other hospitals when a standard option (cuff or conver-
sion) is not considered anymore. Finally, this study reﬂects
the outcomes of two high-volume referral centers for F-
EVAR. Thus, reproducibility of similar good results in a
wider scale including less experienced institutions may be
questionable.CONCLUSION
Our results indicate that F-EVAR should be considered to
treat patients with proximal complications after EVAR when
an adequate infrarenal neck is not present anymore. If
technically successful, F-EVAR after EVAR clearly represents
a less morbid alternative to open conversion. However,
increased technical difﬁculties due to the pre-existing stent-
graft have to be expected, both with planning andexecution of the procedure. Technical failure leads to worse
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